Oruka Therapeutics, Inc.
ORKA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000907654
In the last 90 days, Oruka Therapeutics, Inc. insiders filed 0 open-market purchases and 15 sales; 255 institutions reported holding it in 13F filings for Q2 2026, worth $7.05B in total; Viking Global Investors is the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding Oruka Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 22 | 24 | +2 |
| Shares | 1.13M | 1.68M | +542.7K (+47.9%) |
| Value | $2.60M | $4.17M | +$1.57M (+60.2%) |
New holders (7)
Institutions that held Oruka Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 227,917 | $568.0K | 0.00% |
| Group One Trading, L.P. | 131,501 | $327.0K | 0.01% |
| Murchinson Ltd. | 50,593 | $126.0K | 0.02% |
| Bailard, Inc. | 35,000 | $87.0K | 0.00% |
| Renaissance Technologies LLC | 32,500 | $81.0K | 0.00% |
| SG3 Management, LLC | 22,706 | $57.0K | 0.11% |
| Two Sigma Securities, LLC | 10,238 | $25.0K | 0.00% |
Sold out (5)
Institutions that held Oruka Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Virtu Financial LLC | 23,874 | $55.0K |
| Tower Research Capital LLC (TRC) | 4,951 | $11.0K |
| Simplex Trading, LLC | 2,604 | $5.00K |
| Citigroup Inc | 1,790 | $4.00K |
| JPMorgan Chase & Co | 675 | $2.00K |